0000950170-24-010972.txt : 20240202
0000950170-24-010972.hdr.sgml : 20240202
20240202213044
ACCESSION NUMBER: 0000950170-24-010972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sommadossi Jean-Pierre
CENTRAL INDEX KEY: 0001296995
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 24593710
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-01-31
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001296995
Sommadossi Jean-Pierre
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
true
true
false
false
President, CEO, and Chairman
true
Common Stock
2024-01-31
4
M
false
173467
A
173467
D
Common Stock
2024-02-01
4
S
false
56910
3.8450
D
116557
D
Common Stock
5925000
I
Held by JPM Partners LLC
Restricted Stock Units
2024-01-31
4
M
false
173467
0
D
Common Stock
173467
346933
D
Stock Option (Right to Buy)
4.16
2024-01-31
4
A
false
448000
0
A
2034-01-30
Common Stock
448000
448000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated May 18, 2023.
The original grant of 520,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
2024-02-02